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Background: Adverse fetal environments predispose offspring to pathologies associated with the metabolic
syndrome. Previously we demonstrated that adult offspring of dexamethasone-treated mothers had elevated
plasma insulin and pro-inflammatory cytokines, effects prevented by a postnatal diet enriched with omega (n)-3
fatty acids. Here we tested whether prenatal glucocorticoid excess also programmed the adipose tissue phenotype,
and whether this outcome is rescued by dietary n-3 fatty acids.
Methods: Offspring of control and dexamethasone-treated mothers (0.75 μg/ml in drinking water, day 13 to term)
were cross-fostered to mothers on a standard (Std) or high n-3 (Hn3) diet at birth. Offspring remained on these
diets post-weaning, and serum and retroperitoneal fat were obtained at 6 months of age (n = 5-8 per group).
Serum was analysed for blood lipids and fatty acid profiles, adipocyte cross sectional area was measured by
unbiased stereological analysis and adipose expression of markers of inflammation, glucocorticoid sensitivity and
lipid metabolism were determined by RT-qPCR analysis.
Results: Serum total fatty acid levels were elevated (P < 0.01) in male offspring of dexamethasone-treated mothers,
an effect prevented by Hn3 consumption. Prenatal dexamethasone also programmed increased adipose expression
of Il6, Il1b (both P < 0.05) and Tnfa (P < 0.001) mRNAs regardless of fetal sex, but again this effect was prevented (for
Il6 and Il1b) by Hn3 consumption. Offspring of dexamethasone-treated mothers had increased adipose expression
of Gr (P = 0.008) and Ppara (P < 0.05) regardless of sex or postnatal diet, while 11bHsd1 was upregulated in males
only. The Hn3 diet increased Ppard expression and reduced adipocyte size in all offspring (both P < 0.05) irrespective
of prenatal treatment.
Conclusions: Prenatal glucocorticoid exposure programmed increased expression of inflammatory markers and
enhanced glucocorticoid sensitivity of adipose tissue. Partial prevention of this phenotype by high n-3 consumption
indicates that postnatal dietary manipulations can limit adverse fetal programming effects on adipose tissue.Background
The incidence of obesity and related metabolic disorders
(hypertension, insulin resistance and dyslipidemia) have
risen dramatically in recent decades, with major implica-
tions for cardiovascular disease risk [1]. There is growing
evidence that a range of insults in early life, including in
utero, can developmentally program adverse outcomes
for the adult phenotype. Most notably, undernutrition,
overnutrition and glucocorticoid excess can all program* Correspondence: peter.mark@uwa.edu.au
1School of Anatomy, Physiology & Human Biology, The University of Western
Australia, Perth, Australia
Full list of author information is available at the end of the article
© 2014 Mark et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.adverse phenotypic outcomes. Accordingly, offspring born
small (a proxy for a poor fetal environment) are predis-
posed to several adult-onset diseases including diabetes
and obesity [2,3]. We previously demonstrated that off-
spring of rat mothers treated with dexamethasone during
pregnancy were growth retarded at birth and as adults,
were hyperleptinemic, hyperinsulinemic and hypertensive
[4]. These offspring also exhibited a pro-inflammatory
state, with plasma levels of tumor necrosis factor alpha
(TNFα), interleukin 6 (IL6) and IL1β all increased by
prenatal dexamethasone [5]. Moreover, because this pro-
inflammatory state and most other adverse programming
outcomes were prevented by postnatal dietary omega (n)-3d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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mation may be a key driver of the overall programmed
phenotype [5]. In particular, adipose tissue inflammation
may underlie the programmed pro-inflammatory pheno-
type, since adipose tissue leptin expression was elevated in
offspring that had been exposed prenatally to dexametha-
sone [4]. To test this hypothesis we characterised the
adipose tissue phenotype and serum fatty acid profiles in
adult offspring of dexamethasone-treated mothers. Specif-
ically, we measured adipocyte size (by unbiased stereology)
and adipose expression of pro-inflammatory cytokines,
peroxisome proliferator-activated receptors, and determi-
nants of glucocorticoid sensitivity (i.e., the glucocorticoid
receptor (GR; Nr3c1) and 11β-hydroxysteroid dehydro-
genase (11bHsd) enzymes). This focus on adipose gluco-
corticoid sensitivity was considered important given
that enhanced glucocorticoid activity in adipocytes ap-
pears to be obesogenic (for review see [6]). Moreover,
because the programmed phenotype in our model was
largely rescued in offspring raised on a diet enriched with
n-3 fatty acids [4,5] we also characterised the adipose
phenotype and fatty acid profiles of these offspring.
Methods
Animals and diets
Nulliparous albino Wistar rats aged between 8 and
10 weeks were obtained from the Animal Resources
Centre (Murdoch, Australia) and maintained under
controlled lighting and temperature as previously de-
scribed [7]. Two isocaloric, semi-pure diets were used in
this study, each formulated with identical ratios of pro-
tein, carbohydrate, fat, and salt, but with markedly dif-
ferent n-3 fatty acid contents as previously described
[4]. The Hn3 diet contained 34% of total fats as long
chain n-3 fatty acids whereas the standard diet contained
0.8% n-3 fatty acids. The semi-pure diets were manufac-
tured by Specialty Feeds (Glen Forrest, Australia) and
were sterilized by gamma-irradiation. Ten days before
mating, half the females were placed on one of the two
semi-pure diets; standard (Std) or high omega-3 fatty acids
(Hn3), while the others remained on a normal rat chow
(Specialty Feeds, Glen Forrest, Australia). All rats were
provided with acidified water and food ad libitum. All
procedures involving animals were approved by the
Animal Ethics Committee of The University of Western
Australia. Rats were mated overnight and the day on
which spermatozoa were present in a vaginal smear was
designated day 1 of pregnancy. Dexamethasone (Dex)
acetate (Sigma Chemical Co., St Louis, MO, USA) was
administered in the drinking water (0.75 μg/ml) from
day 13 until birth in half of the pregnancies. Previous
studies show that dexamethasone acetate administered
via maternal drinking water results in consistent, dose-
dependent reductions in birth weight [8]. In the currentstudy, birth weight was reduced by 24% and 25% in
males and females, respectively, as previously reported
[4]. Within 24 h of birth, all pups from control (Con)
and Dex-treated mothers were cross-fostered to a mother
consuming either a Std diet or Hn3 diet. Cross-fostering
resulted in four treatment groups (Con/Std, Con/Hn3,
Dex/Std and Dex/Hn3), and pups remained with their fos-
ter mothers until weaning, at which point male and female
offspring were caged separately and remained on their al-
located diets (Std or Hn3).
Tissue collection
At 6 months of age, a male and female were randomly
selected from each litter, fasted overnight for 16 h,
weighed and anesthetized with 40 mg/kg Nembutal
(Rhone Merieux, Pinkenba, Australia). Blood was col-
lected from the dorsal aorta and serum stored at −20°C
until subsequent analysis. Retroperitoneal adipose tissue
samples were collected and either fixed (Histochoice)
or snap frozen in liquid nitrogen and stored at −80°C
until analysis.
Measurement of blood lipids
Serum total cholesterol and triacylglycerols were deter-
mined enzymatically on a Cobas MIRA analyser (Roche
Diagnostics, Basel, Switzerland) with reagents from
Trace Scientific (Melbourne, Australia). High density
lipoprotein-cholesterol (HDL-C) was determined on a
heparin-manganese supernatant [9]. The intra-assay co-
efficients of variation were 2.2% at 4.2 mM and 1.4% at
10.5 mM for total cholesterol, 1.6% at 4.0 mM and 2.5%
at 1.2 mM for triacylglycerols, and 1.9% at 1.1 mM for
HDL-C. In each case all samples were measured in a
single assay. Serum levels of a range of fatty acids were
analysed by gas chromatography as previously described
[10]. Briefly, serum (200 μL) was extracted with 2 ml
chloroform/methanol (2:1, v/v). Fatty acid methyl esters
were prepared by treatment of total lipid extracts with
4% H2SO4 in methanol at 90°C for 20 min and analysed
by gas liquid chromatography using a Hewlett-Packard
model 5980A gas chromatograph (Hewlett Packard,
Rockville, MD). The samples were resolved on a BPX70
column (25 cm × 0.32 mm, 0.25 μm film thickness;
SGE, Ringwood, Victoria, Australia) with a temperature
program increasing from 150°C to 210°C at 4°C/min
and using N2 as the carrier gas at a split ratio of 30:1.
Peaks were identified by comparison with a known
standard mixture.
Adipose tissue morphometry
Fixed retroperitoneal fat samples (n = 5 per group) from
male rats were processed and embedded in paraffin wax.
Three sections (3 μm thick) were cut (random starting
section and orientation) with a distance between sections
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eosin before dehydration in graded alcohols and mounting
in DPX for morphometrical analysis. Estimation of the
mean area of unilocular adipocytes was performed using
an unbiased stereological technique which involved a
Cavalieri grid overlay (grid size: 20 μm) [11]. Images were
observed at x 20 magnification and 100 cells per section
in 3 sections were chosen by systematic uniform sampling.
Grid points falling onto the region of interest were
counted (Stereo Investigator, MBF Bioscience, Williston,
VT) and area estimates were calculated by multiplying the
number of grid points counted by the area associated per
grid point [12]. Results were adjusted for shrinkage during
processing as determined by the measurement of 100
erythrocyte diameters and comparison with the standard
diameter of erythrocytes in Wistar rats [13].Table 1 Primer sequences and conditions for quantitative PC
Gene Sequence Cycling condit
11bHsd1 F: 5` ctctctgtgtcctcggcttc 3` 95°C/1 sec
R: 5` ttccatgatcctccttcctg 3` 57°C/15 sec
72°C/5 sec
Adiponectin F: 5` tggcagagatggcactcc 3` 95°C/1 sec
R: 5` cttccgctcctgtcattcc 3` 59°C/15 sec
72°C/5 sec
GR F: 5` cttgagaaacttacacctcgatgacc 3` 95°C/1 sec
R: 5` agcagtaggtaaggagattctcaacc 3` 62°C/20 sec
72°C/30 sec
Il1b QT00182896 95°C/1 sec
60°C/30 sec
Il6 QT00181657 95°C/1 sec
60°C/30 sec
Pgc1a F: 5` tctggaactgcaggcctaactc 3` 95°C/1 sec
R: 5` gcaagagggcttcagctttg 3` 60°C/15 sec
72°C/5 sec
Ppara F: 5` aatccacgaagcctacctga 3` 95°C/1 sec
R: 5` gtcttctcagccatgcacaa 3` 60°C/15 sec
72°C/5 sec
Ppard F: 5` gaggggtgcaagggcttctt 3` 95°C/1 sec
R: 5` cacttgttgcggttcttctg 3` 60°C/15 sec
72°C/5 sec
Pparg F: 5` catgcttgtgaaggatgcaag 3` 95°C/1 sec
R: 5` ttctgaaaccgacagtactgacat 3` 63°C/15 sec
72°C/5 sec
Tnfa F: 5` tactgaacttcggggtgattggtcc 3` 95°C/1 sec
R: 5` cagccttgtcccttgaagagaacc 3` 60°C/30 sec
Rpl19 F: 5`ctgaaggtcaaagggaatgtg 3` 95°C/1 sec
R: 5`ggacagagtcttgatgatctc 3` 52°C/15 sec
72°C/5 secMeasurement of mRNA expression by quantitative
RT-PCR analysis
Total RNA was extracted from tissue samples using an
RNeasy Lipid Tissue kit (Qiagen, Melbourne, Australia).
RNA (1 μg) was reverse transcribed at 42°C for 120 min
using murine Moloney Leukemia Virus Reverse Tran-
scriptase (Promega, Madison, WI, USA) according to
the manufacturer’s instructions and supplemented with
2.5 mg/mL Ficoll 400 and 7.5 mg/mL Ficoll 70 [14]. The
resultant cDNA was purified using the UltraClean PCR
Clean-up Kit (MoBio Laboratories Inc., Solana Beach,
CA, USA). All primers, other than Il6, Il1b and Rpl19,
were designed using Primer3 software [15], and were po-
sitioned to span introns to prevent amplification from
contaminating genomic DNA; ribosomal Rpl19 was used
as an internal control [16]. Quantitect primer sets for Il6R












Table 2 Serum triacylglycerols, cholesterol and HDL-C in
6-month old offspring of control (Con) and
dexamethasone (Dex)-treated mothers
Con/Std Dex/Std Con/Hn3 Dex/Hn3
Triaclyglycerols
(mM)
Male 1.05 ± 0.23 0.75 ± 0.05 0.51 ± 0.03* 0.44 ± 0.04*
Female 0.89 ± 0.12 1.16 ± 0.16 0.62 ± 0.06* 0.53 ± 0.05*
Cholesterol
(mM)
Male 2.53 ± 0.30 2.20 ± 0.11 1.94 ± 0.14* 1.53 ± 0.14*
Female 2.47 ± 0.16 2.05 ± 0.09 1.88 ± 0.07* 1.73 ± 0.19*
HDL-C (mM)
Male 1.93 ± 0.30 1.75 ± 0.11 1.57 ± 0.14 1.29 ± 0.14
Female 1.67 ± 0.16 1.34 ± 0.10 1.41 ± 0.07 1.39 ± 0.19
Offspring were raised on either a standard (Std) or a high omega-3 (Hn3) diet.
Values are the mean + SEM (n = 5–8 per group).
*P < 0.05 compared to corresponding Std diet (three-way ANOVA and
LSD test).
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Qiagen (Melbourne, Australia) and amplified in Quantifast
SYBR Green PCR mix according to the manufacturer’s
instructions. For each of the remaining genes, the PCR
primer sequences are shown in the Table 1 along with the
presence or absence of 2.5 mg/mL Ficoll 400 and 7.5 mg/
mL Ficoll 70 [14], MgCl2 concentrations, annealing tem-
peratures, and PCR product sizes. External standards were
generated from regular PCR products and ten-fold serial
dilutions of the PCR product were made in RNase-free
water (1- to 107 - fold dilutions). Quantitative PCR was
performed in 10 μL reaction volumes using the Rotor-
Gene 6000 system (Corbett Research, Sydney, Australia)
with primer concentrations as specified in the Table 1,
Immolase enzyme (0.5 U; Bioline, Alexandria, Australia),
and 1/40 000 dilution of stock SYBR Green (Molecular
Probes, Eugene, OR, USA) per reaction. The PCR cycling
conditions included an initial denaturation at 94°C for
10 min followed by 45 cycles at 94°C for 1 s; an annealing
temperature (specified in Table 1) for 15 s; and 72°C for
5 s. In each case, melt-curve analysis from 70 to 99°C
showed a single PCR product that was confirmed to be the
correct size and sequence by gel electrophoresis and se-
quence analysis respectively (data not shown). Fluores-
cence values were analyzed, standard curves constructed
using the RotorGene software (Corbett Research, Sydney,
Australia), and all samples standardized against a reference
control (Rpl19).
Statistical analysis
All data are expressed as mean ± S.E.M., with each litter
representing an ‘n’ of one. Analysis of variance (ANOVA)
was used to attribute variation to sex, prenatal treatment,
and postnatal diet. Where the F test was statistically sig-
nificant (P < 0.05), specific differences were assessed by
post hoc least significant difference (LSD) tests [17]. When
a significant interaction term was observed, further ana-
lyses of data subsets were made by ANOVA or unpaired
t tests as appropriate.
Results
Blood lipid profiles and adipocyte size
As previously reported male and female offspring of
dexamethasone-treated mothers in this cohort were born
smaller and had not shown catch-up growth by 6 months
of age [4]. Male and female offspring that consumed the
Std diet had comparable levels of serum triacylglycerols,
cholesterol and HDL-C (Table 2). Postnatal consumption
of the Hn3 diet lowered (P < 0.05) serum triacylglycerols
(by 40-50% in males; 30-55% in females) and cholesterol
(by 25-30% in males; 15-25% in females). Consumption of
the Hn3 diet also reduced (by 20%; P = 0.02) adipocyte
cross sectional area in male offspring irrespective of pre-
natal treatment (Figure 1B).Serum fatty acid profile
Total fatty acid levels in serum were substantially ele-
vated (81%; P < 0.01) in male (Table 3) but not female
(data not shown) offspring of dexamethasone-treated
mothers raised on the Std diet. In contrast, prenatal
dexamethasone had minimal effect on serum fatty acid
levels of offspring raised on the Hn3 diet (Table 2) with
only C16:0, C18:0 and total fatty acid content increased.
As expected, however, offspring raised on the Hn3 diet
had elevated levels of all n-3 fatty acids, but lower levels
of the n-6 fatty acids C20:4 and C22:4. Dietary effects in
female offspring broadly paralleled those in males (re-
sults not shown).
Programming of adipose cytokine expression
Adipose expression of both Il6 and Il1b mRNAs were
upregulated by prenatal dexamethasone exposure (1.6-3-
fold, P < 0.05) in male and female offspring raised on a
Std diet, but these programmed increases were prevented
in offspring raised on the Hn3 diet (Figure 2). Adipose
expression of Tnfa mRNA was also elevated (2–3.5-fold,
P < 0.001) in offspring of dexamethasone-treated mothers
(Figure 2) regardless of postnatal diet. There was also a
sex effect on adipose Tnfa expression (males < females;
P = 0.006), and adipose expression of adiponectin was
not affected by either prenatal dexamethasone or post-
natal diet (data not shown).
Glucocorticoid sensitivity of adipose tissue
Maternal dexamethasone treatment increased (P < 0.05)
adipose GR mRNA expression irrespective of diet in both
male and female offspring (Figure 3A & C). Adipose
expression of 11bHsd1 was also upregulated (P < 0.05)
in male but not female offspring of dexamethasone-
Figure 1 Interactive effects of prenatal dexamethasone exposure and postnatal diet on adipose tissue cross-sectional area at 6 months
of age in male rats. Histological images of retroperitoneal adipose tissue (A) and stereological quantitation of cross-sectional area of adipocytes
(B). Control (Con) group in clear bars, Dex-exposed (Dex) group in black bars. Values are mean ± SEM (n = 5-8). Values without common notation
differ significantly (P < 0.05; one-way ANOVA, LSD).
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diet (Figure 3B & D).
Adipose expression of PPARs
Maternal dexamethasone treatment increased adipose
expression of Ppara (P = 0.008) in both male and female
offspring regardless of diet (Figure 4). In contrast, Ppard
expression was unaffected by prenatal dexamethasone
but was upregulated (1.5-1.8-fold, P < 0.05) by consump-
tion of the Hn3 diet at (Figure 4). Adipose expression of
Pparg was unaffected by prenatal dexamethasone or post-
natal diet in both males and females (results not shown).
The PPAR co-activator, Pgc1a, was unaffected by prenataltreatment but was higher (P < 0.05) in male (but not fe-
male) offspring raised on the Hn3 diet (Figure 4C).
Discussion
Fetal glucocorticoid excess is recognised as a key mechan-
ism involved in the programming of adverse phenotypic
outcomes in adult offspring, including hypertension and
insulin resistance. The present study showed that prenatal
dexamethasone exposure programmed increased adipose
inflammation and serum fatty acid levels at 6 months of
age, and that consumption of a postnatal diet enriched
with n-3 fatty acids alleviated many of these adverse
outcomes. Specifically, adipose expression of Tnfa, Il6,
Table 3 Serum concentrations of fatty acids (μg/mL) in
male offspring at 6 months of age
Con/Std Dex/Std Con/Hn3 Dex/Hn3
C14:0 8 ± 1a 20 ± 2b 11 ± 1ac 16 ± 3bc
C16:0 155 ± 7a 289 ± 19b 165 ± 8a 215 ± 18c
C18:0 83 ± 9a 140 ± 9b 46 ± 5c 63 ± 9a
C16:1(n-7) 33 ± 4a 65 ± 9 b 53 ± 7 b 64 ± 3 b
C18:1 (n-9) 175 ± 15a 315 ± 28b 94 ± 8c 120 ± 11c
C18:2 (n-6) 53 ± 6a 125 ± 11b 58 ± 3a 79 ± 11a
C20:3 (n-6) 5 ± 1a 8 ± 1b 3 ± 0.5a 4 ± 0.5a
C20:4 (n-6) 225 ± 46a 372 ± 41b 63 ± 4c 73 ± 5c
C20:5 (n-3) 2 ± 0.5a 4.6 ± 0.4b 97 ± 9c 108 ± 14c
C22:4 (n-6) 3 ± 0.5a 9 ± 1a 0.5 ± 0.5b 0.5 ± 0.5b
C22:5 (n-3) 3 ± 0.5a 6 ± 1b 16 ± 1c 22 ± 3c
C22:6 (n-3) 25 ± 2a 46 ± 5b 66 ± 4c 83 ± 13c
Total n6 228 ± 46a 354 ± 48b 63 ± 4c 74 ± 5c
Total n3 30 ± 2a 54 ± 7b 179 ± 11c 213 ± 29c
Total 769 ± 65ac 1398 ± 86b 672 ± 27a 846 ± 94c
Data were analysed by two-way ANOVA followed by post hoc LSD tests.
Where there was an interaction between treatment and diet, separate t-tests
were performed. For each fatty acid (i.e. within each row), values without
common notation (a, b, c) differ significantly (P < 0.05).
Values are the mean ± SEM (n = 7 to 8 per group).
Figure 2 Interactive effects of prenatal dexamethasone exposure and
expression in adipose tissue in male (A-C) and female (D-F) rats. Cont
Values are mean ± SEM (n = 5-8). Values without common notation differ si
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(males only) were all elevated in adult offspring of
dexamethasone-treated mothers. Consumption of a diet
enriched with n-3 fatty acids from birth corrected the
programmed increases in serum fatty acids and adipose
expression of Il6 and Il1b. Dietary supplementation with
n-3 fatty acids also upregulated expression of Ppard
and reduced mean adipocyte size regardless of prenatal
treatment.
Disturbances to the normal fetal environment, such as
excess glucocorticoid exposure or undernutrition, have
been associated with a predisposition for adverse physio-
logical outcomes in adult offspring including type II dia-
betes, hypertension and obesity in humans [18,19] and rats
[4,5,20-22]. Our developmental programming model in-
volves fetal glucocorticoid excess over the final third of rat
pregnancy, which leads to fetal growth restriction [4,7,23]
and subsequent development of offspring hypertension,
hyperleptinemia [4], hyperinsulinemia and elevated plasma
cytokine levels [5]. Although percent adiposity appeared
unaffected in these programmed offspring [4], the present
study shows that fetal glucocorticoid excess programmed
marked changes in the adipose tissue phenotype. Most not-
ably, adipose mRNA expression of the pro-inflammatory
cytokines Tnfa, Il6 and Il1b was elevated in male and fe-
male offspring of dexamethasone-treated mothers, consist-
ent with our previous report showing that plasma levels of
these cytokines were elevated in this same cohort of ani-
mals [5]. Furthermore, although insulin sensitivity was notpostnatal diet on Tnfa (A, D), Il6 (B, E) and Il1b (C, F) mRNA
rol (Con) group in clear bars, Dex-exposed (Dex) group in black bars.
gnificantly (P < 0.05; two-way ANOVA, LSD).
Figure 3 Interactive effects of prenatal dexamethasone exposure and postnatal diet on GR (A, C) and 11bHsd1 (B, D) mRNAs in
adipose tissue in male (A-B) and female (C-D) rats. Control (Con) group in clear bars; dexamethasone (Dex) group in black bars. Values are
mean ± SEM (n = 5-8). Values without common notation differ significantly (P < 0.05; two-way ANOVA, LSD).
Figure 4 Interactive effects of prenatal dexamethasone exposure and postnatal diet on Ppara (A, D), Ppard (B, E) and Pgc1a (C, F)
mRNA expression in adipose tissue in male (A-C) and female (D-F) rats. Control (Con) group in clear bars, Dex-exposed (Dex) group in black
bars. Values are mean ± SEM (n = 5-8). Values without common notation differ significantly (P < 0.05; two-way ANOVA, LSD). *P < 0.05 compared to
Std diet.
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indicated that prenatal dexamethasone treatment resulted
in hyperinsulinemia [5]. This suggests that the pro-
inflammatory state of adipose tissue may contribute to
systemic inflammation and insulin resistance. Moreover,
programming of the pro-inflammatory adipose pheno-
type was largely prevented when offspring were raised
on the Hn3 diet, which normalised both Il6 and Il1b
expression (but interestingly not that of Tnfa) and cir-
culating insulin levels. This partial correction i.e. nor-
malisation of Il6 and Il1b but not Tnfa, parallels the
effects of the Hn3 diet on systemic inflammatory state
[5] and the anti-inflammatory effects of the high n-3 diet
are consistent with observations in a range of previous
animal and human studies (for review see [24]). Exactly
why programmed Tnfa expression is not corrected is un-
clear and requires further investigation.
A second key feature of the programmed adipose tis-
sue phenotype was an apparent increase in glucocortic-
oid sensitivity, a characteristic linked to the aetiology of
obesity [25-27]. Thus, adipose expression of both the
GR (Nr3c1) and 11bHsd1 mRNAs were both increased
in offspring of dexamethasone-treated mothers. Gluco-
corticoid activation of the GR is enhanced by local expres-
sion of 11βHSD1, which catalyses regeneration of active
corticosterone from inert 11-dehydrocorticosterone [28].
As such, these changes, coupled with increased stress-
responsiveness of programmed offspring in this model
[29], are likely to promote GR activation in adipose tissue.
These observations extend those of Gnanalingham et al.
(2005), who showed that prenatal dexamethasone expos-
ure in a sheep model increased GR and 11βHSD1 levels in
perirenal adipose tissue of newborns [30]. Our data are
also consistent with the programmed upregulation of GR
expression in kidney [31] and liver [32] following prenatal
dexamethasone, and in adipose tissue after maternal un-
dernutrition [22]. Collectively, these studies show that
adipose glucocorticoid sensitivity is enhanced by fetal in-
sults (nutritional or excess glucocorticoids).
This outcome might be expected to reduce adipose in-
flammation, given that glucocorticoids are normally po-
tent anti-inflammatory agents. Indeed, glucocorticoids
and pro-inflammatory cytokines are thought to act syn-
ergistically to stimulate 11bHsd1 expression in acute
inflammation, thereby further enhancing local levels of
active glucocorticoid to perhaps limit inflammation (for
review see [6]). But if this acute inflammation is not re-
solved and chronic inflammation ensues, as in metabolic
disease, the anti-inflammatory action of glucocorticoids
appears to be lost [6]. Interestingly, a similar scenario is
evident in the late gestation rat placenta, where increased
expression of pro-inflammatory cytokines [33], GR and
11bHsd1 [23] all occur despite rising levels of maternal
and fetal glucocorticoids.The PPAR transcription factors play key roles in adipo-
cyte differentiation and function, influencing the balance
between fat storage (via PPARγ) and utilisation (via
PPARδ) (for reviews see [34,35]). Although prenatal dexa-
methasone did not affect adipose expression of either
Pparg or Ppard, it did program a marginal increase in adi-
pose expression of Ppara, particularly in female offspring.
This effect may have developed as a compensatory re-
sponse to the heightened adipose inflammatory state, since
PPARα activation is known to exert anti-inflammatory ef-
fects in other cell types [36]. Interestingly, these Ppard
responses to diet are different to those observed in the
skeletal muscle of the same rats [5], where elevated Ppard
expression was programmed by prenatal Dex exposure,
but was unaffected by diet. This likely represents tissue-
specific regulation of Ppard.
Male offspring of dexamethasone-treated mothers
showed elevated serum levels of total fatty acids, an
effect evident across all fatty acid groups. While the spe-
cific reasons why this effect was limited to male off-
spring are not known, gender differences have been
noted in fatty acid oxidation rates in humans (females
lower than males; for review see [37]). Although previ-
ous studies have reported a programmed increase in
serum free fatty acid and triacylglycerol levels (by ma-
ternal obesity; [38]), importantly this was observed in
offspring that were themselves obese. In contrast, the
programmed increase in serum fatty acids in the present
study occurred in the absence of increased adiposity,
possibly indicative of a greater susceptibility to obesogenic
stimuli. It is possible that the programming of elevated
serum fatty acids by dexamethasone may be linked, in
part, to the elevated levels of pro-inflammatory cytokines
[5], since these cytokines are known to increase lipolysis
in both humans and rats [39,40]. In this context it is note-
worthy that adipose expression of Il6 was also corrected
by the Hn3 diet.
Consumption of the Hn3 diet markedly reduced serum
levels of triacylglycerols and cholesterol, but did not
affect HDL-C levels, consistent with known effects of n-
3 fatty acids on lipid profiles in humans [41]. This diet-
ary effect may reflect inhibition of hepatic triacylglycerol
synthesis and stimulation of beta-oxidation by n-3 fatty
acids [42], effects that are likely to have contributed to
the decreased adipocyte size in rats fed the Hn3 diet.
Elevated expression of Ppard was also observed in these
smaller adipocytes, consistent with previous studies in
rats that consumed n-3 fatty acids [43]. Activation of
PPARδ in adipocytes leads to improved lipid profiles and
reduced adiposity [44] and n-3 fatty acids are known li-
gands for PPARs [45]. Decreased adipocyte size has also
been associated with increased insulin sensitivity, a reduced
incidence of type II diabetes in rats [46] and humans [47]
as well as reduced expression and release of adipocytokines
Mark et al. Reproductive Biology and Endocrinology 2014, 12:39 Page 9 of 10
http://www.rbej.com/content/12/1/39[48,49], suggestive of a less detrimental phenotype associ-
ated with the smaller adipocytes. Furthermore, this re-
duced adipocyte size is consistent with the observed
decline in epididymal fat pad weight previously reported
for these animals [4].
Conclusions
This study demonstrates that prenatal dexamethasone
exposure programmed detrimental changes in the adipo-
cyte phenotype including a pro-inflammatory state and
increased glucocorticoid sensitivity. Consumption of a
postnatal diet enriched with n-3 fatty acids attenuated
pro-inflammatory adipocytokine responses, decreased adi-
pose cross-sectional area and alleviated many of these ad-
verse programming effects of fetal glucocorticoid excess.
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